Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Phase 1 Study of IMP321 (Eftilagimod Alpha) Adjuvant to Anti-PD-1 Therapy in Unresectable or Metastatic Melanoma

NCT02676869

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Royal Brisbane Womens Hospital Brisbane, Queensland, Australia

Princess Alexandra Hospital Brisbane, Queensland, Australia

Greenslopes Private Hospital Brisbane, Queensland, Australia

Flinders Medical Centre Adelaide, South Australia, Australia

View Trial Details

Completed

Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer

NCT01445379

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +31 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

AZD7451 for Recurrent Gliomas

NCT01468324

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients

NCT01222728

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +31 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Collection of Tissue Samples for Study of Multidrug Resistance

NCT00880503

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma, +17 more
Locations: Childrens Hospital, Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)

NCT01295827

Conditions: Cancer, Solid Tumor, Carcinoma, Melanoma, +17 more
Locations: Not specified

View Trial Details

Completed

Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer

NCT00304460

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

AZD8055 for Adults With Recurrent Gliomas

NCT01316809

Conditions: Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Astrocytoma, +24 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction

NCT00145041

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Natural History of Patients With Brain and Spinal Cord Tumors

NCT00009035

Conditions: Anaplastic Glioma, Astrocytoma, Central Nervous System Neoplasms, +15 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions